Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Gila Idelman, Eric M Jacobson, Traci R Tuttle & Nira Ben-Jonathan. (2011) Lactogens and estrogens in breast cancer chemoresistance. Expert Review of Endocrinology & Metabolism 6:3, pages 411-422.
Read now
Read now
Articles from other publishers (16)
Ashley Sutherland, Amanda Forsyth, Yingying Cong, Laurel Grant, Tzu-Hua Juan, Jae K. Lee, Alexander Klimowicz, Stephanie K. Petrillo, Jinghui Hu, Angela Chan, Florence Boutillon, Vincent Goffin, Cay Egan, Patricia A. Tang, Li Cai, Don Morris, Anthony Magliocco & Carrie S. Shemanko. (2016) The Role of Prolactin in Bone Metastasis and Breast Cancer Cell–Mediated Osteoclast Differentiation. Journal of the National Cancer Institute 108:3, pages djv338.
Crossref
Crossref
Caroline M. Gorvin. (2015) The prolactin receptor: Diverse and emerging roles in pathophysiology. Journal of Clinical & Translational Endocrinology 2:3, pages 85-91.
Crossref
Crossref
Chi Zhang, Ibtissem Cherifi, Mads Nygaard, Gitte W. Haxholm, Roman L. Bogorad, Marie Bernadet, Patrick England, Isabelle Broutin, Birthe B. Kragelund, Jacques-Emmanuel Guidotti & Vincent Goffin. (2015) Residue 146 regulates prolactin receptor folding, basal activity and ligand-responsiveness: Potential implications in breast tumorigenesis. Molecular and Cellular Endocrinology 401, pages 173-188.
Crossref
Crossref
Anne BachelotNadège CarréOlivier MialonMelody MatelotNathalie ServelPhilippe MongetPetteri Ahtiainen, Ilpo Huhtaniemi & Nadine Binart. (2013) The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis. American Journal of Physiology-Endocrinology and Metabolism 305:7, pages E845-E852.
Crossref
Crossref
Alyson A. Fiorillo, Terry R. Medler, Yvonne B. Feeney, Suzanne M. Wetz, Kalie L. Tommerdahl & Charles V. Clevenger. (2013) The Prolactin Receptor Transactivation Domain Is Associated with Steroid Hormone Receptor Expression and Malignant Progression of Breast Cancer. The American Journal of Pathology 182:1, pages 217-233.
Crossref
Crossref
Robert Dagil, Maiken J. Knudsen, Johan G. Olsen, Charlotte O'Shea, Magnus Franzmann, Vincent Goffin, Kaare Teilum, Jens Breinholt & Birthe B. Kragelund. (2012) The WSXWS Motif in Cytokine Receptors Is a Molecular Switch Involved in Receptor Activation: Insight from Structures of the Prolactin Receptor. Structure 20:2, pages 270-282.
Crossref
Crossref
Sarah J Nyante, Jessica M Faupel-Badger, Mark E Sherman, Ruth M Pfeiffer, Mia M Gaudet, Roni T Falk, Abegail A Andaya, Jolanta Lissowska, Louise A Brinton, Beata Peplonska, Barbara K Vonderhaar, Stephen Chanock, Montserrat Garcia-Closas & Jonine D Figueroa. (2011) Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland. Breast Cancer Research 13:2.
Crossref
Crossref
Lisa M Arendt, Debra E Rugowski, Tara A Grafwallner-Huseth, Maria Jose Garcia-Barchino, Hallgeir Rui & Linda A Schuler. (2011) Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer. Breast Cancer Research 13:1.
Crossref
Crossref
Eric M. Jacobson, Eric R. Hugo, Traci R. Tuttle, Ruben Papoian & Nira Ben-Jonathan. (2010) Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor. Trends in Endocrinology & Metabolism 21:11, pages 691-698.
Crossref
Crossref
Vincent Goffin, Roman L. Bogorad & Philippe Touraine. 2010. Constitutive Activity in Receptors and Other Proteins, Part A. Constitutive Activity in Receptors and Other Proteins, Part A
329
355
.
Alexandr Plotnikov, Bentley Varghese, Thai H. Tran, Chengbao Liu, Hallgeir Rui & Serge Y. Fuchs. (2009) Impaired Turnover of Prolactin Receptor Contributes to Transformation of Human Breast Cells. Cancer Research 69:7, pages 3165-3172.
Crossref
Crossref
Roman L. Bogorad, Carine Courtillot, Chidi Mestayer, Sophie Bernichtein, Lilya Harutyunyan, Jean-Baptiste Jomain, Anne Bachelot, Frédérique Kuttenn, Paul A. Kelly, Vincent Goffin & Philippe Touraine. (2008) Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors. Proceedings of the National Academy of Sciences 105:38, pages 14533-14538.
Crossref
Crossref
Gary L. BratthauerBrian L. StraussRoss Barner. (2008) Reversed Expression of the JAK/STAT Pathway Related Proteins Prolactin Receptor and STAT5a in Normal and Abnormal Breast Epithelial Cells. Breast Cancer: Basic and Clinical Research 1, pages BCBCR.S549.
Crossref
Crossref
Sulggi A Lee, Christopher A Haiman, Noel P Burtt, Loreall C Pooler, Iona Cheng, Laurence N Kolonel, Malcolm C Pike, David Altshuler, Joel N Hirschhorn, Brian E Henderson & Daniel O Stram. (2007) A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the Multiethnic Cohort. BMC Medical Genetics 8:1.
Crossref
Crossref
Annika Vaclavicek, Kari Hemminki, Claus R. Bartram, Kerstin Wagner, Barbara Wappenschmidt, Alfons Meindl, Rita K. Schmutzler, Rüdiger Klaes, Michael Untch, Barbara Burwinkel & Asta Försti. (2006) Association of Prolactin and Its Receptor Gene Regions with Familial Breast Cancer. The Journal of Clinical Endocrinology & Metabolism 91:4, pages 1513-1519.
Crossref
Crossref
Y Li, C V Clevenger, N Minkovsky, K G S Kumar, P N Raghunath, J E Tomaszewski, V S Spiegelman & S Y Fuchs. (2006) Stabilization of prolactin receptor in breast cancer cells. Oncogene 25:13, pages 1896-1902.
Crossref
Crossref